Skip to main content
Edwards Lifesciences Logo

The JOURNEY LVAD trial

LVAD patients hero

About the JOURNEY LVAD trial

About the trial

The JOURNEY LVAD trial is a clinical trial studying whether the J-Valve Transfemoral (TF) system is safe and effective in people with severe aortic regurgitation (AR) and a left ventricular assist device (LVAD).

Trial locations

You can find a participating hospital near you by visiting ClinicalTrials.gov.
If you have any questions about the trial, please contact our Patient Support Center.

Map

What is aortic regurgitation

Aortic Regurgitation (AR) is also known as aortic insufficiency, and is diagnosed when your aortic valve allows blood to leak back into your heart instead of moving forward into your aorta.

What is aortic regurgitation

Normally, your aortic heart valve opens and closes to let blood flow from your heart's left ventricle, into your aorta, and out through your body. A leaking (or regurgitant) valve means your valve doesn't close all the way and allows the blood to flow backwards into your ventricle.

When your blood moves backwards, it forces your heart to work harder to push blood out to your body. This extra work causes your heart to grow in size (enlarge). Over time as your heart enlarges, the extra work can create symptoms and even lead to heart failure.

Symptoms can include:

chest pain

Chest pain

Lightheadedness or fainting

Lightheadedness or fainting

Fatigue and weakness

Fatigue and weakness

Rapid heartbeat

Rapid heartbeat

Shortness of breath

Shortness of breath

Swelling of the feet

Swelling of the feet

What is TAVR-AR

Transcatheter Aortic Valve Replacement for Aortic Regurgitation (TAVR-AR) may be a less invasive procedure for patients who are at high risk for open heart surgery. The purpose of the TAVR-AR procedure is to replace your diseased aortic valve with a bioprosthetic valve (a man-made valve containing animal tissue). 

We are studying the safety and performance of the investigational J-Valve device for patients with AR and a LVAD. This replacement is one way to treat aortic regurgitation or aortic valve insufficiency.

What is TAVR-AR

The Edwards J-Valve transcatheter heart valve
Investigational  Device

1 / 5
Step 1
Step 2
Step 2
Step 4
Step 5
Step 1
Step 2
Step 2
Step 4
Step 5

Step 1

For the TAVR procedure, a small incision will be made in your leg. Through here, your doctor will insert a thin tube, called a catheter, into your artery.

Step 2

The study valve is compressed and attached to the end of the catheter. The catheter will be pushed through your blood vessels up to your heart using x-ray guidance.

Step 3

Special anchor rings are placed around your leaflets. These will help the study valve stay in place inside your heart.

Step 4

The study valve is then placed within the anchor rings. It expands into place inside your diseased aortic valve.

Step 5

The study valve holds your diseased valve open and takes over its function. After the study valve is implanted, your doctor will remove the catheter and delivery device, and close the incision in your leg.

Learn more about the procedure

1 / 2
English version

English version

Spanish version

Spanish version

Eligibility criteria

You may be eligible for this trial if you:

  • have severe, symptomatic, aortic regurgitation; and
  • have a left ventricular assist device (LVAD)

Your doctor and/or research team will discuss with you the full list of criteria for participating in this trial.

Eligibility criteria

Frequently asked questions

contact us lady

We're here for you

We are committed to providing the highest levels of customer service to help our patients improve their quality of life. For any questions, please contact the Edwards Patient Support Center

For details about the trial, visit NCT07363473 at Clinical Trials.gov.

Give us a call

888.713.1564
CAUTION: Investigational device.

CAUTION: Investigational device. Limited by Federal (United States) law to investigational use. 

PP--US-12229 v1.0